ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CTEC Convatec Group Plc

282.60
-1.00 (-0.35%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.35% 282.60 282.60 283.00 283.20 279.80 281.80 4,198,441 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 44.43 5.79B

ConvaTec Group PLC Director Declaration (9321C)

20/06/2019 2:20pm

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 9321C

ConvaTec Group PLC

20 June 2019

ConvaTec Director Declaration

Reading, United Kingdom (20 June 2019)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Margaret Ewing, Senior Independent Non-Executive Director of the Company, has been appointed as an Independent Non-Executive Director of International Consolidated Airlines Group, S.A, with effect from today.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                +44 (0)7770 842 226 

Alastair Elwen, Finsbury +44 (0)207 251 3801

Analysts and Investors

   John Crosse, VP Investor Relations, ConvaTec                           +44 (0)7500 141 435 
   Mark Reynolds, Director Investor Relations, ConvaTec                +44 (0)7551 036 625 

investorrelations@convatec.com

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNPGUWGQUPBGWU

(END) Dow Jones Newswires

June 20, 2019 09:20 ET (13:20 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock